A toxicity study of trimetrexate used in combination with сyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants

Transplantation

Volumn 60, Issue 1, 1995, Pages 55-58

  Doney, Kristine C ^a   Storb, Rainer ^b   Beach, Kathy ^b   Anasetti, Claudio ^b   Deeg, H Joachim ^b   Hansen, John A ^b   Martin, Paul J ^b   Nash, Richard A ^b   Schubert, Mark M ^b   Sullivan, Keith M ^b   Witherspoon, Robert P ^b   Appelbaum, Frederick R ^b  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TRIMETREXATE;

ADULT; ALLOGRAFT; ARTICLE; BIOTRANSFORMATION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; KIDNEY DISEASE; LIVER FUNCTION; PRIORITY JOURNAL; SURVIVAL; URINARY EXCRETION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMAN; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TRIMETREXATE;

EID: 0029072788     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199507150-00011     Document Type: Article

References (12)

1. Anasetti C, Beatty PG, Storb R, et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79.
2. Storb R, Deeg HJ, Farewell V, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119.
3. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclo sporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729.
4. Nash RA, Pepe MS, Storb R, et al. Acute graft-versus-host dis ease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838.
5. Lin JT, Bertino JR. Trimetrexate: a second generation folate antagonist in clinical trial. J Clin Oncol 1987; 5: 2032.
6. Appelbaum FR, Raff RF, Storb R, et al. Use of trimetrexate for the prevention of graft-versus-host disease. Bone Marrow Transplant 1989; 4: 421.
7. Deeg HJ, Storb R, Appelbaum FR, Kennedy MS, Graham TC, Thomas ED. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates. Transplantation 1984; 37: 62.
8. Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med 1975; 292: 832.
9. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992; 69: 2469.
10. Storb R, Pepe M, Anasetti C, et al. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 1990; 76: 1037.
11. Wilkinson GR, Shand DG. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 1975; 18: 377.
12. Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729.